Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125815201 | 12581520 | 1 | I | 20160711 | 20160721 | 20160721 | EXP | JP-BAUSCH-BL-2016-017249 | BAUSCH AND LOMB | GOCHO N, AOKI E, OKADA C, OMURA K, HIRASHIMA T, SUZUKI N. NON-OCCLUSIVE MESENTERIC ISCHEMIA WITH DIABETIC KETOACIDOSIS AND LACTIC ACIDOSIS FOLLOWING THE ADMINISTRATION OF A SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITOR. INTERNAL MEDICINE. 2016;55(13):1755-1760. | 60.00 | YR | M | Y | 72.80000 | KG | 20160721 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125815201 | 12581520 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | Y | 21748 | ||||||||||
| 125815201 | 12581520 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | Y | 21748 | 1000 | MG | ||||||||
| 125815201 | 12581520 | 3 | SS | CANAGLIFLOZIN | CANAGLIFLOZIN | 1 | Unknown | Y | 0 | 300 | MG | ||||||||
| 125815201 | 12581520 | 4 | C | INSULIN ASPART | INSULIN ASPART | 1 | BEFORE EACH MEAL (6 TO 10 UNITS) | 0 | |||||||||||
| 125815201 | 12581520 | 5 | C | INSULIN GLARGINE | INSULIN GLARGINE | 1 | ONCE IN THE MORNING (24 UNITS) | 0 | |||||||||||
| 125815201 | 12581520 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | 100 | UG | ||||||||||
| 125815201 | 12581520 | 7 | C | LOSARTAN. | LOSARTAN | 1 | 0 | 100 | MG | ||||||||||
| 125815201 | 12581520 | 8 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125815201 | 12581520 | 1 | Type 2 diabetes mellitus |
| 125815201 | 12581520 | 3 | Type 2 diabetes mellitus |
| 125815201 | 12581520 | 4 | Type 2 diabetes mellitus |
| 125815201 | 12581520 | 5 | Type 2 diabetes mellitus |
| 125815201 | 12581520 | 6 | Product used for unknown indication |
| 125815201 | 12581520 | 7 | Product used for unknown indication |
| 125815201 | 12581520 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125815201 | 12581520 | OT |
| 125815201 | 12581520 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125815201 | 12581520 | Diabetic ketoacidosis | |
| 125815201 | 12581520 | Lactic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |